1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
New Exercise Study Brings Both Illumination and Questions
Simon McGrath looks at new objective evidence of abnormal response to exercise in ME/CFS patients, and the questions that researchers are still trying to answer ...
Discuss the article on the Forums.

Article: Roche releases Phase III results of Rituximab on Lymphoma

Discussion in 'Rituximab: News and Research' started by HopingSince88, May 23, 2010.

  1. HopingSince88

    HopingSince88 Senior Member

    Messages:
    335
    Likes:
    5
    Maine
    "Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from the Phase III PRIMA study. The data showed that continuing MabThera (rituximab) for two years in patients who responded to initial treatment with MabThera plus chemotherapy, doubled the likelihood of them living without their disease worsening, known as progression-free survival (PFS), compared to those who did not receive maintenance."

    Link:

    http://www.roche.com/media/media_releases/med-cor-2010-05-21.htm
  2. camas

    camas Senior Member

    Messages:
    697
    Likes:
    196
    Oregon
    This is good news for those with follicular lymphoma.
  3. HopingSince88

    HopingSince88 Senior Member

    Messages:
    335
    Likes:
    5
    Maine

See more popular forum discussions.

Share This Page